Medtronic MiniMed recalled 95,704 MiniMed 770G insulin pumps worldwide after finding insulin delivery can misbehave when the pump height changes. Over-delivery can cause severe hypoglycemia and death; under-delivery can cause hyperglycemia and death. Stop using the device and follow the manufacturer’s recall instructions immediately.
Quick Facts at a Glance
Recall Date
February 13, 2026
Hazard Level
HIGH
Brand
Medtronic MiniMed
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL
Hazard Information
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
What You Should Do
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic MiniMed, Inc. or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
No spamUnsubscribe anytime
About This Product
This insulin pump delivers continuous subcutaneous insulin to people with diabetes. The MiniMed 770G and related pumps are used to automate insulin delivery.
Why This Is Dangerous
The device’s height relative to the infusion site can alter insulin flow due to hydrostatic and hydrodynamic pressure changes. Over-delivery risks hypoglycemia and death; under-delivery risks hyperglycemia, dehydration, DKA, and death.
Industry Context
This recall is not stated as part of a broader industry pattern.
Real-World Impact
Consumers could face life-threatening diabetes complications if the device mis-delivers insulin. The recall involves a large, global population of users.
Practical Guidance
How to identify if yours is affected
Identify your pump model and serial or UDI labels.
Compare your model against the affected list (MMT-1880, 1881, 1882, 1890, 1891, 1892).
Check packaging and device labels for model numbers and UDI codes.
Where to find product info
Look on the device label, user guide, and original packaging for model numbers and UDI. Manufacturer recall notices will detail next steps.
What timeline to expect
Refund or replacement processing will follow manufacturer instructions; typical recall timelines range from several weeks to a few months.
If the manufacturer is unresponsive
Document all communications with the manufacturer.
Contact your healthcare provider for interim insulin management guidance.
If the manufacturer is nonresponsive, file a consumer complaint with federal safety agencies.
How to prevent similar issues
Avoid purchasing older Paradigm, 600 series, or BLE 700 series pumps for replacement until updated guidance is issued.
Verify recall status before replacing devices.
Ask clinicians about non-pump insulin management during a recall window.
Documentation advice
Keep the recall notice, your pump’s model and serial numbers, purchase receipts, and all communications with the manufacturer and healthcare providers.
Product Details
Product: MiniMed 770G Insulin Pump
Brand: Medtronic MiniMed
Models: MMT-1880, MMT-1881, MMT-1882, MMT-1890, MMT-1891, MMT-1892
Distribution: Worldwide, including US states and international markets
Original recall date: 2026-02-13
Recall number: Z-1742-2026
Quantity: 95,704 units
Associated series: Paradigm, 600 series, BLE 700 series
URL: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-1742-2026
Price: Unknown
Sold since: Unknown
Reported Incidents
No injuries or incidents have been reported.
Key Facts
95,704 units recalled worldwide
Affects Paradigm, 600 series, and BLE 700 series pumps
Recall date 2026-02-13; active status
Over-delivery can cause severe hypoglycemia and death; under-delivery can cause severe hyperglycemia
Stop using immediately and follow manufacturer instructions
Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.
Mazda North American Operations recalls 2025 Mazda CX-70 plug-in hybrids as software issues in the inverter may cause the malfunction indicator lights to illuminate and a loss of drive power in EV mode. Dealers will update inverter software at no cost. Letters were mailed December 19, 2024.
Mazda North American Operations recalls certain 2024-2025 CX-90 and 2025 CX-70 vehicles with a Dash ESU due to startup function failures. Software reprogramming will remedy the issue at no charge. Owner notices were mailed December 18, 2024. Contact Mazda at 1-800-222-5500 Option 6. NHTSA ID 24V814000.
Subaru recalls 2025 Forester vehicles due to potentially loose child seat anchor bolts. Dealers will inspect and tighten bolts at no charge. Owner letters are expected August 15, 2025. Contact Subaru at 1-844-373-6614. Recall number WRC-25.
Nissan recalls 2025 Pathfinder, Murano and INFINITI QX60 for front brake caliper weakness that could fail. Dealers will inspect and replace calipers as needed, free of charge. Letters sent May 9, 2025. Contact Nissan or INFINITI for remedies.
Mazda North American Operations is recalling 2025 CX-50 Hybrid and CX-50 SUVs sold through Mazda dealers. Incorrectly configured restraint-control software may cause the air bag to deploy improperly. Owner notification letters are expected to be mailed August 17, 2025.
Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.
Chrysler is recalling 2024-2025 Pacifica minivans after a radio installed during production could fail to display the rearview camera image. Dealers will replace the radio at no cost. Owner letters were mailed August 7, 2025. Contact Chrysler customer service at 800-853-1403 for details.